Assessment of gold nanoparticles on human peripheral blood cells by metabolic profiling with 1H-NMR spectroscopy, a novel translational approach on a patient-specific basis

PLoS One. 2017 Aug 9;12(8):e0182985. doi: 10.1371/journal.pone.0182985. eCollection 2017.

Abstract

Human peripheral blood cells are relevant ex vivo models for characterizing diseases and evaluating the pharmacological effects of therapeutic interventions, as they provide a close reflection of an individual pathophysiological state. In this work, a new approach to evaluate the impact of nanoparticles on the three main fractions of human peripheral blood cells by nuclear magnetic resonance spectroscopy is shown. Thus, a comprehensive protocol has been set-up including the separation of blood cells, their in vitro treatment with nanoparticles and the extraction and characterization of metabolites by nuclear magnetic resonance. This method was applied to assess the effect of gold nanoparticles, either coated with chitosan or supported on ceria, on peripheral blood cells from healthy individuals. A clear antioxidant effect was observed for chitosan-coated gold nanoparticles by a significant increase in reduced glutathione, that was much less pronounced for gold-cerium nanoparticles. In addition, the analysis revealed significant alterations of several other pathways, which were stronger for gold-cerium nanoparticles. These results are in accordance with the toxicological data previously reported for these materials, confirming the value of the current methodology.

MeSH terms

  • Erythrocytes / drug effects*
  • Erythrocytes / metabolism
  • Glutathione / metabolism
  • Gold*
  • Humans
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / metabolism
  • Metabolomics
  • Metal Nanoparticles / administration & dosage*
  • Proton Magnetic Resonance Spectroscopy

Substances

  • Gold
  • Glutathione

Grants and funding

The present work was supported by grants CP13/00252 and PI16/02064 from Carlos III Health Institute and by the European Regional Development Fund (ERDF) and the grant SAF2014-53977-R from the Ministry of Economy, Industry and Competitiveness. In addition, JRH is recipient of a Miguel Servet I contract from the Ministry of Health of the Carlos III Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript” instead of “The present work was supported by grants CP13/00252 and PI16/02064 from Carlos III Health Institute, and by the European Regional Development Fund (ERDF). In addition, JRH is recipient of a contract from the Ministry of Health of the Carlos III Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.